TGFB1 and myasthenia gravis: The study findings of the identification of the existence of Bregs and the significant reduction of the number of Bregs in MG as compared to HCs; the reduction of IL-10 and TGF-β1 secretion in patients with MG as compared to HC in this research could contribute to new B cell-mediated therapeutic strategies in future.